www.childcancer.org.uk - Information for patients & families affected by childhood cancer
 
Clinical Trials

Follow up

Many trials of serious illness are conducted to see if a treatment can prevent or delay the occurrence of a major event (eg death, recurrence of cancer, etc.). Such studies usually require long-term follow up. Even when a trial is closed to patient entry (ie when the required number of patients have been recruited), follow up continues.

In trials of childhood cancer, where many children are now surviving many years after treatment, follow up in the centre is carried out indefinitely in order to assess the long-term effects, if any, of treatment. Routine collection of follow up data by the trials unit will usually continue for a defined period (ie 10 years). After that time period it is more likely that specific late effects studies will be conducted in a particular patient population.

>>>> How is trial data analysed/evaluated? >>>>

  1. Introduction
  2. What is a Clinical Trial?
  3. Clinical Trial procedure
  4. The role of the Chief Investigator
  5. The Protocol
  6. How is the size of a clinical trial determined?
  7. What is a multi-centre trial?
  8. Role of coordinating centre/Trials Unit
  9. What is randomisation?
  10. How is a patient randomised for a particular trial?
  11. What is a control in clinical trials?
  12. Forms and data management
  13. Statistics in clinical trials
  1. The role of the trial coordinator
  2. Follow up
  3. How is the trial data analysed/evaluated?
  4. What are pharmacokinetic studies?
  5. Ethical issues
  6. Conduct of Clinical Trials/Research
  7. What is a blind trial?
  8. Interpretation and publication of findings
  9. Survival Curves
  10. UKCCSG Protocols – development and approval process
  11. References
  12. Download PDF
Related information links: